首页> 美国卫生研究院文献>Experimental Molecular Medicine >Reactive oxygen species regulate the generation of urokinase plasminogen activator in human hepatoma cells via MAPK pathways after treatment with hepatocyte growth factor
【2h】

Reactive oxygen species regulate the generation of urokinase plasminogen activator in human hepatoma cells via MAPK pathways after treatment with hepatocyte growth factor

机译:肝细胞生长因子治疗后,活性氧通过MAPK途径调节人肝癌细胞中尿激酶纤溶酶原激活物的生成

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Tumor cells are known to produce larger amounts of reactive oxygen species (ROS) than normal cells. Although numerous reports have indicated the importance of ROS in urokinase plasminogen activator (uPA) production, the precise mechanisms remain controversial. In our study, we investigated the effect of ROS on uPA generation in human hepatoma cells, HepG2 and Hep 3B. We determined the effects of hepatocyte growth factor (HGF) on the regulation of ROS, which resulted in suppression of ROS production, as measured with the fluorescent probe, 2'-7'-dichlorofluorescein diacetate. The role of HGF in modulating ROS production, particularly that regulated by Rac-1, was determined. HGF suppressed the increment in Rac-1-regulated ROS in both cell lines. Treatment with 200 µM of H2O2 showed a 1.6-2.1 fold increment in HGF, but a little increment occurred at 500 µM of H2O2. It looks no dose dependent manner. Combined treatment with H2O2 and HGF, resulted in a slightly increased production of HGF compared to no treatment (control). Also, H2O2 upregulated uPA expression in both hepatoma cell lines. To identify the downstream pathways regulated by ROS, we treated cells with PD 98059, an MEK inhibitor, and SB 203580, a p38 inhibitor, after treatment with H2O2, and showed negative control between ERK and p38 kinase activities for uPA regulation. We found that HGF modulate Rac-1-regulated ROS production through activation of Akt and ROS regulates uPA production via MAP kinase, which provides a novel clue to clarify the mechanism underlying hepatoma progression.
机译:已知肿瘤细胞会比正常细胞产生更多的活性氧(ROS)。尽管大量报道表明ROS在尿激酶纤溶酶原激活剂(uPA)生产中的重要性,但确切的机制仍存在争议。在我们的研究中,我们研究了ROS对人肝癌细胞HepG2和Hep 3B中uPA生成的影响。我们确定了肝细胞生长因子(HGF)对ROS的调节作用,该作用可抑制ROS的产生,如荧光探针2'-7'-dichlorofluorescein diacetate所测。确定了HGF在调节ROS产生中的作用,特别是在Rac-1调节中。 HGF抑制了两种细胞系中Rac-1调节的ROS的增加。用200 µM的H2O2处理后,HGF的含量增加了1.6-2.1倍,但在500 µM的H2O2中出现了少量的增加。它看起来没有剂量依赖性。与未处理(对照)相比,H2O2和HGF的联合处理导致HGF的产量略有增加。同样,H2O2上调了两种肝癌细胞系中的uPA表达。为了确定由ROS调控的下游途径,我们在用过氧化氢处理过后用PD 98059(MEK抑制剂)和SB 203580(p38抑制剂)处理了细胞,并对uPA调节在ERK和p38激酶活性之间显示出负调控。我们发现,HGF通过激活Akt来调节Rac-1调节的ROS产生,并且ROS通过MAP激酶调节uPA的产生,这为阐明肝癌进展的机制提供了新的线索。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号